<DOC>
	<DOCNO>NCT01891799</DOCNO>
	<brief_summary>The purpose study understand best provide care treatment service human immunodeficiency virus ( HIV ) positive pregnant woman baby Swaziland . The study design evaluate new approach Preventing Mother-to-Child Transmission ( PMTCT ) HIV positive pregnant woman initiate lifelong triple antiretroviral ( ARV ) therapy regardless disease stage . The goal prevent delay woman access treatment health ensure woman child remain care . This study compare new approach PMTCT , know Option B+ , Option A , current standard care PMTCT Swaziland . The study conduct 10 health facility Manzini Lubombo region Swaziland . The study three component : main component PMTCT Options Evaluation data medical record abstract HIV positive pregnant woman attend antenatal service 10 select study facility ; data abstract HIV expose infant well . Other component study include PMTCT Options Acceptability Evaluation use semi-structured questionnaire PMTCT client health care worker ( HCWs ) well cost effectiveness evaluation compare cost condition Option A Option B+ .</brief_summary>
	<brief_title>Swaziland Safe Generations</brief_title>
	<detailed_description>Purpose : `` Situkulwane Lesiphephile—Safe Generations '' implementation science research study design evaluate innovative PMTCT strategy include modify Option B approach , HIV positive pregnant woman initiate lifelong triple antiretroviral ( ARV ) therapy independent CD4+ count ( Option B+ ) HIV positive pregnant postpartum woman infant engage structured appointment follow-up protocol currently available woman receive antiretroviral therapy ( ART ) . The study hypothesize single , uniform streamline treatment retention approach HIV positive pregnant woman eliminate delay , prevent loss : ( 1 ) result high proportion mother infant successfully complete PMTCT cascade few new pediatric infection ; ( 2 ) lead high proportion ART-eligible woman initiate triple ART earlier pregnancy ; ( 3 ) feasible implement ; 4 ) great acceptability among staff patient ; 5 ) cost-effective compare Option A . Design : Stepped wedge design 10 health facility one facility transition Option A Option B+ approach every month 12 month . Outcome measure compare Option A Option B+ condition sit well transition site . Routinely collect data facility register medical record abstract determine study outcome . In addition , two purposely select cohort ( 1 ) 120 PMTCT client ; ( 2 ) approximately 50 health care worker complete questionnaire repeat time point assess acceptability Option A Option B+ approach . Study Population : All HIV positive pregnant woman ART engage PMTCT service study sit part PMTCT Options Evaluation . This include HIV+ woman ART enrol PMTCT service pregnant woman newly test HIV+ absolute neutrophil count ( ANC ) . A subset HIV+ pregnant woman ART engage PMTCT service health care worker provide PMTCT service study sit enrol acceptability evaluation . Study Size : A total approximately 2,600 HIV positive pregnant woman enrol PMTCT service ten Ministry Health ( MOH ) facility . Primary Objective : To compare impact implement Option A Option B+ composite endpoint infant HIV-positive polymerase chain reaction ( PCR ) 6 month postpartum maternal loss follow-up 6 month postpartum . Secondary Objectives : 1 . To compare Option A Option B+ proportion pregnant woman CD4+ &lt; 350 cells/mm3 initiate ART pregnancy duration ART receive prior delivery ART-eligible pregnant woman 2 . To compare Option A Option B+ proportion woman child retain HIV care 12 , 18 month postpartum 3 . To examine patient provider level acceptability Option A Option B+ 4 . To compare cost-effectiveness Option A Option B+ Tertiary Objectives : 1 . To determine pregnancy infant outcome ( include fetal loss , neonatal death , birth weight gestational age ) among HIV+ pregnant woman receive PMTCT compare outcomes maternal ARV regimen . 2 . To compare Option A Option B+ maternal child adherence measure prescription dispense maternal infant antiretroviral medication .</detailed_description>
	<criteria>Women least 18 year age Documented pregnancy ( per routine ANC protocol set ) Documented HIVinfection ( per routine ANC protocol set ) Infants bear eligible enrolled woman • Women already ART enter ANC</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>HIV/AIDS</keyword>
	<keyword>PMTCT</keyword>
	<keyword>Option B+</keyword>
	<keyword>Swaziland</keyword>
</DOC>